Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

Introduced in House Aug 13, 2026 · 1.4K words Open full page ↗

119TH CONGRESS

2D SESSION

H. R. 10094

To require persons who undertake federally funded research and development

of a biomedical product or service to enter into reasonable pricing agree-

ments with the Secretary of Health and Human Services, and for other

purposes.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 2%, measured from US's completed sessions
Momentum -0 49/100 from the pace of recorded action
Time since last action -5 58 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.